- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Richard Willke Previews ISPOR 2017 in Boston
Richard J. Willke, PhD, chief science officer of ISPOR, previews the discussions at the ISPOR 22nd Annual International Meeting, which will be held May 20-24 in Boston, Massachusetts, including topics on the future of health policy in the United States and social networking interventions.
Richard J. Willke, PhD, chief science officer of ISPOR, previews the discussions at the ISPOR 22nd Annual International Meeting, which will be held May 20-24 in Boston, Massachusetts, including topics on the future of health policy in the United States and social networking interventions.
Transcript
As ISPOR prepares for the annual meeting in Boston in May, how is it handling the uncertainty of an Affordable Care Act repeal? What other topics will the meeting focus on?
Our first plenary in Boston is going to feature a panel of 4 leading health economists. Two that have worked with the Democrats—Jonathan Gruber and David Cutler—and 2 that have tended to work with Republicans—Joe Antos and Gail Wilensky. Given what just happened [with the American Health Care Act] we expect it to be a very lively discussion.
Our second plenary is on the leading edge of how we look at healthcare behaviors. It's called "Social Networking Interventions and Population Health." And it's being given by Nicholas Christakis of Yale. I'm really anxious to hear that one. And our third one will be very aligned with what we talked about [at AMCP 2017]. The title is "When Do You Really Need Randomized Clinical Trials?" And we'll have Sebastian Schneeweiss and Rob Califf, who was just FDA commissioner, and Steven Goodman to talk about those topics.
Plus, about another 100 sessions on a variety of current scientific and policy topics. So we're really excited about it.
Contributor: More Informed Management of Preeclampsia Is Necessary
November 29th 2023At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Provisional CDC data show that US babies gained roughly a year in life expectancy in 2022; study findings indicate that the COVID-19 pandemic significantly raised the risk of preterm birth for expectant California mothers; New York Attorney General Letitia James said about 4 million New Yorkers were affected by a data breach of the medical transcription company Perry Johnson & Associates.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Gene Therapy Success in UK Likely Depends on Overcoming Education, Psychological Support Challenges
November 27th 2023Education, psychological support, and implementation guidance are the top unmet needs identified by investigators from the United Kingdom concerning gene therapy use for hemophilia.
Read More
